Dendrite Appoints Jeff Bairstow as Executive Vice President and Chief Financial Officer.

BEDMINSTER, N.J. -- Dendrite International, Inc. (NASDAQ: DRTE), the leading provider of sales, marketing, clinical and compliance solutions for the global pharmaceutical industry, today announced the appointment of Jeff Bairstow as Executive Vice President and Chief Financial Officer, effective December 20, 2005.

Mr. Bairstow joins Dendrite from RelayHealth Corporation, the nation's premier provider of health plan-reimbursed online doctor-patient communication services, where he has served as Chief Operating Officer since 2004.

Mr. Bairstow previously held senior financial and operational responsibilities within Health Net Inc. (NYSE: HNT), including as President of Health Net's Government and Specialty Services Division and earlier as Executive Vice President and Chief Financial Officer of Health Net-California. Mr. Bairstow also held a number of executive positions at other public and private companies within the healthcare industry, including America Service Group (NASDAQ: ASGR) and Managed Health Network, after beginning his career at Ernst & Whinney.

"When Dendrite approached me I became enthused by the remit to help them take a leading role in providing the solutions that integrate the promotional activities and improve the productivity of the global pharmaceutical industry. I am very pleased to join the team charged with growing the company into this enormous opportunity."

"Jeff is a broadly skilled executive who brings strong leadership and financial experience to Dendrite. He will lead the maturation of our financial and other management processes to help ensure we are appropriately structured for the growth we see ahead. Additionally, as a senior, experienced healthcare executive, he will be invaluable as he joins Joe Ripp in driving Dendrite's innovation as we reach for higher levels of performance," said John Bailye, Dendrite's Chairman and Chief Executive Officer.

Mr. Bairstow graduated from Vanderbilt University in 1980 with a Bachelor of Arts degree and earned his Master's of Business Administration in 1982 from Vanderbilt's Owen School of Business.

About Dendrite

Founded in 1986, Dendrite International (NASDAQ: DRTE) provides diversified sales, marketing, clinical and compliance solutions to the global life sciences and pharmaceutical industry. With clients in more than 50 countries, including the world's top 20 pharmaceutical companies, Dendrite strives to be the first source for expert promotional and sales effectiveness solutions. For more information, please visit www.dendrite.com.

Note: Dendrite is a registered trademark of Dendrite International, Inc.

This document may contain forward-looking statements that may be identified by such forward-looking terminology as "expect," "believe," "anticipate," "will," "intend," "plan," "target," "outlook," "guidance," and similar statements or variations. Such forward-looking statements are based on our current expectations, estimates, assumptions and projections and involve significant risks and uncertainties, including risks which may result from our dependence on the pharmaceutical industry; fluctuations in quarterly revenues due to lengthy sales and implementation cycles for certain of our solutions; our fixed expenses in relation to fluctuating revenues and variations in customers' budget cycles; dependence on certain major customers; changes in demand for our products and services attributable to any weakness experienced in the economy or mergers, acquisitions and consolidations in the pharmaceutical industry; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; international operations; integrating the entities we acquire; our ability to effectively manage our growth; the protection of our proprietary technology; our ability to compete in the Internet-related products and services market; the continued demand for Internet-related products and services; the ability of our third party vendors to respond to technological change; our ability to maintain our relationships with third-party vendors; less favorable than anticipated results from strategic relationships; dependence of data solutions on strategic relationships; events which may affect the U.S. and world economies; and catastrophic events which could negatively affect our information technology infrastructure. Other important factors that should be reviewed and carefully considered are included in the company's 10-K, 10-Qs, and other reports filed with the SEC. Actual results may differ materially. The company assumes no obligation for updating any such forward-looking statements to reflect actual results, changes in assumptions or other changes affecting such forward-looking statements.